[go: up one dir, main page]

NO20035566L - Prebiotiske kombinasjonsprodukter - Google Patents

Prebiotiske kombinasjonsprodukter

Info

Publication number
NO20035566L
NO20035566L NO20035566A NO20035566A NO20035566L NO 20035566 L NO20035566 L NO 20035566L NO 20035566 A NO20035566 A NO 20035566A NO 20035566 A NO20035566 A NO 20035566A NO 20035566 L NO20035566 L NO 20035566L
Authority
NO
Norway
Prior art keywords
prebiotic
prophylaxis
small amount
combination products
prebiotic combination
Prior art date
Application number
NO20035566A
Other languages
English (en)
Other versions
NO320546B1 (no
NO20035566D0 (no
Inventor
Jan Yngvar Piene
Original Assignee
Nova Biotics As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nova Biotics As filed Critical Nova Biotics As
Priority to NO20035566A priority Critical patent/NO320546B1/no
Publication of NO20035566D0 publication Critical patent/NO20035566D0/no
Priority to AT04808876T priority patent/ATE424832T1/de
Priority to EP04808876A priority patent/EP1696937B1/en
Priority to PCT/NO2004/000382 priority patent/WO2005056023A1/en
Priority to DE602004019968T priority patent/DE602004019968D1/de
Publication of NO20035566L publication Critical patent/NO20035566L/no
Publication of NO320546B1 publication Critical patent/NO320546B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/733—Fructosans, e.g. inulin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
    • A23L29/244—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin from corms, tubers or roots, e.g. glucomannan
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/718—Starch or degraded starch, e.g. amylose, amylopectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Nutrition Science (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Mycology (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Medicines Containing Plant Substances (AREA)
NO20035566A 2003-12-12 2003-12-12 Prebiotiske kombinasjonsprodukter NO320546B1 (no)

Priority Applications (5)

Application Number Priority Date Filing Date Title
NO20035566A NO320546B1 (no) 2003-12-12 2003-12-12 Prebiotiske kombinasjonsprodukter
AT04808876T ATE424832T1 (de) 2003-12-12 2004-12-10 Präbiotische kombinationsprodukte
EP04808876A EP1696937B1 (en) 2003-12-12 2004-12-10 Prebiotic combination products
PCT/NO2004/000382 WO2005056023A1 (en) 2003-12-12 2004-12-10 Prebiotic combination products
DE602004019968T DE602004019968D1 (de) 2003-12-12 2004-12-10 Präbiotische kombinationsprodukte

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NO20035566A NO320546B1 (no) 2003-12-12 2003-12-12 Prebiotiske kombinasjonsprodukter

Publications (3)

Publication Number Publication Date
NO20035566D0 NO20035566D0 (no) 2003-12-12
NO20035566L true NO20035566L (no) 2005-06-13
NO320546B1 NO320546B1 (no) 2005-12-19

Family

ID=30439651

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20035566A NO320546B1 (no) 2003-12-12 2003-12-12 Prebiotiske kombinasjonsprodukter

Country Status (5)

Country Link
EP (1) EP1696937B1 (no)
AT (1) ATE424832T1 (no)
DE (1) DE602004019968D1 (no)
NO (1) NO320546B1 (no)
WO (1) WO2005056023A1 (no)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY144556A (en) * 2005-10-24 2011-09-30 Nestec Sa Dietary fiber formulation and method of administration
EP2086346B1 (en) 2006-11-07 2013-01-16 The Procter & Gamble Company Fiber containing compositions and methods of making and using same
US20080254166A1 (en) * 2007-01-25 2008-10-16 Potter Susan M Food Additives Containing Combinations of Prebiotics and Probiotics
US7767248B2 (en) 2007-02-02 2010-08-03 Overly Iii Harry J Soft chew confectionary with high fiber and sugar content and method for making same
DE102008059070B4 (de) 2008-11-26 2019-05-16 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Zusammensetzung zur therapeutischen oder prophylaktischen Behandlung von Durchfallerkrankungen und/oder zur Aufrechterhaltung und/oder Wiederherstellung der natürlichen Darmflora, Dosiereinheit, Verpackungseinheit und Verwendung der Zusammensetzung
EP2216036A1 (en) * 2009-02-10 2010-08-11 Nestec S.A. Lactobacillus rhamnosus NCC4007, a probiotic mixture and weight control
GB0907019D0 (en) * 2009-04-24 2009-06-03 Oxford Nutrascience Ltd Pharmaceutical,therapeutic or nutritional delivery systems for functional ingredients
DE102011012494A1 (de) 2011-02-25 2012-08-30 Humana Milchunion Eg Prebiotische Kohlenhydrat-Zusammensetzungen
US10117885B2 (en) * 2011-08-11 2018-11-06 Allergy Research Group, Llc Chewable lipid supplements for treating pain and fibromyalgia
US11253531B2 (en) 2011-08-11 2022-02-22 Nutritional Therapeutics, Inc. Lipid supplements for reducing nerve action potentials
BR112016025876B1 (pt) 2014-05-05 2023-03-14 Basf Se Composição, processo para preparar uma composição, e, produto
WO2017027601A1 (en) * 2015-08-11 2017-02-16 Shaklee Corporation Materials and methods for improving gastrointestinal health
US20190275076A1 (en) * 2018-03-08 2019-09-12 Coöperatie Koninklijke Cosun U.A. Dietary fiber compositions for curative or prophylactic treatment of obesity and other conditions
EP3556226B1 (de) * 2018-04-20 2021-01-20 Raab Vitalfood GmbH Komplex-synbiotikum zum aufbau einer gesunden darmflora
EP3806879A4 (en) * 2018-06-15 2022-03-09 University Of Tasmania PREPARATION FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE USING A WHOLE PLANT FIBROUS EXTRACT FROM SUGAR CANE
RU2713154C1 (ru) * 2018-10-04 2020-02-04 Игорь Юрьевич Чичерин Антихеликобактерное средство и способ его применения
CN110652009B (zh) * 2019-10-23 2023-03-17 四川拜奥德克生物科技有限公司 一种高纤维膳食补充剂用于预防及改善骨代谢相关疾病的新用途
CN113476472A (zh) * 2021-07-22 2021-10-08 中国科学院烟台海岸带研究所 一种用于缓解肠道紊乱的益生元组合物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0756828B2 (en) * 1995-08-04 2010-09-22 N.V. Nutricia Nutritional composition containing fibres
EP2179726A3 (en) * 1995-12-26 2012-09-26 Block Drug Company, Inc. Dietary fiber inulin delivery system
US6203797B1 (en) * 1998-01-06 2001-03-20 Stephen C. Perry Dietary supplement and method for use as a probiotic, for alleviating the symptons associated with irritable bowel syndrome
US6436446B1 (en) * 1999-07-30 2002-08-20 Pharmavite Llc Composition for increasing bone density
WO2001064225A1 (en) * 2000-03-01 2001-09-07 Societe Des Produits Nestle S.A. Carbohydrate formulation (prebiotic adjuvant) for enhancement of immune response
EP1175905A1 (en) * 2000-07-24 2002-01-30 Societe Des Produits Nestle S.A. Nutritional Composition
EP1243273A1 (en) * 2001-03-22 2002-09-25 Societe Des Produits Nestle S.A. Composition comprising a prebiotic for decreasing infammatory process and abnormal activation of non-specific immune parameters
EP1386546A1 (en) * 2002-07-31 2004-02-04 Ca.Di.Group S.r.l. Association of prebiotics and colonic foods intended to help and keep the physiological health and the functional capacity of the intestine

Also Published As

Publication number Publication date
ATE424832T1 (de) 2009-03-15
WO2005056023A1 (en) 2005-06-23
NO320546B1 (no) 2005-12-19
EP1696937B1 (en) 2009-03-11
EP1696937A1 (en) 2006-09-06
DE602004019968D1 (de) 2009-04-23
NO20035566D0 (no) 2003-12-12

Similar Documents

Publication Publication Date Title
ATE424832T1 (de) Präbiotische kombinationsprodukte
TW200731973A (en) Pharmaceutical compositions and dosage forms of thalidomide
CY1116093T1 (el) Χρηση νιντεντανιμπης για την αγωγη της πνευμονικης ινωσεως
EA200600041A1 (ru) Применение изомальта (смеси 1,6-gps и 1,1-gpm) в качестве пребиотика, в частности, для получения лекарственного средства для лечения кишечных заболеваний
MXPA05009595A (es) Compuestos 7-amino-isoindolilo y sus usos farmaceuticos.
ES2569061T3 (es) Isomaltulosa en productos cereales
MX2009003305A (es) Inhibidores de co-transportador de glucosa de sodio 2 y metodo para su uso.
DK1841332T3 (da) Fortykningskomposition til dysfagi patienter
IL180979A0 (en) Isoindoline compounds and methods of making and using the same
MY145311A (en) Method for stimulating the intestinal flora
NO20064041L (no) Substituerte pyrazolin sammensetninger, deres fremstilling og anvendelse som medikamenter
TW200621317A (en) Pharmaceutical composition
EA200900044A1 (ru) Замещенные производные 1,3-дифенилпропана, получение и их применение
TW200738269A (en) Oral delivery of therapeutic agents using tight junction agonists
BRPI0615989B8 (pt) formulação farmacêutica de dosagem oral
UA90893C2 (ru) Пероральная дозированная форма производных гемцитабина
RU2009115791A (ru) Смесь солей железа и меди, маскирующая металлический вкус
MX2010007033A (es) Compuestos para el tratamiento selectivo del componente inmunoinflamatorio intestinal de la enfermedad celiaca.
AR013739A1 (es) Composiciones de agentes reductores de lipidos
EA201000854A1 (ru) Применение эдта и ее солей для профилактики и лечения дизентерии свиней и усиления эффектов антибиотиков, проявляющихся при этом заболевании
TNSN05065A1 (en) Use of prebiotics for the treatment and prevention of hyperglycaemic syndromes
CL2008003438A1 (es) Producto liquido nutricional de administracion oral que comprende un antagonista del receptor vanilloide 1 (vr-1) y su uso para tratar la disfagia oral faringea.
EA200900259A1 (ru) Лечение ревматоидного заболевания глюкокортикоидами с отсроченным высвобождением
MX2009010763A (es) NUEVO REGIMEN DE DROSPIRENONA/17ß-ESTRADIOL, PRODUCTO FARMACEUTICO COMBINADO Y CONJUNTO DE ELEMENTOS (KIT) PARA SU APLICACION.
RS20060662A (en) 4-phenyl-pyrimidine-2-carbonitrile derivatives

Legal Events

Date Code Title Description
CREP Change of representative

Representative=s name: JAN YNGVAR PIENE, UNDELSTAD TERRASSE 25 B, 1387 AS

MM1K Lapsed by not paying the annual fees